D.C. Diagnosis By Nicholas Florko As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
Exclusive By Nicholas Florko Senate FDA legislation will include dietary supplement, cosmetic reforms
Politics By Lev Facher Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?
Politics By Lev Facher The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
Pharmalot By Ed Silverman Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Mysterious infections, dwindling Covid funds, & Shkreli out of prison
First Opinion By Brian Wallach and Mike Braun Take a stand for those who can’t with the Promising Pathway Act
Politics By Nicholas Florko Congress moves toward reforming FDA accelerated approvals, but with pharma-friendly concessions
D.C. Diagnosis By Nicholas Florko The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids
Politics By Rachel Cohrs Five of Congress’ 10 biggest health earmarks went to Missouri clinics and universities
Politics By Rachel Cohrs Manchin won’t support new health policy unless Congress rolls back Trump tax cuts
Politics By Nicholas Florko Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies
Exclusive By Rachel Cohrs White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process
First Opinion By Walter G. Johnson and Diana M. Bowman It’s time for Congress to stop blocking mitochondrial replacement therapy
Exclusive By Nicholas Florko Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules
Politics By Rachel Cohrs Biden administration ramps up long Covid research efforts following criticism
D.C. Diagnosis By Nicholas Florko Faced with high drug prices, seniors are abandoning cancer drugs at the pharmacy
First Opinion By Constantinos Michaelidis and Candra Szymanski Home care instead of hospital care: Congress should extend a crucial waiver
Exclusive By Lev Facher Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist
Exclusive By Lev Facher Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence